Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Report Fourth Quarter and Year End 2015 Financial Results and Provide a Corporate Update on Thursday, March 10, 2016

SAN RAMON, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics...
February 16, 2016 17:00 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Proposed Settlement of Derivative Litigation

SAN RAMON, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (the "Company"), (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of...
February 08, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Notice of Allowance of U.S. Patent for NeuVax™ (nelipepimut-S)

SAN RAMON, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
February 02, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the BIO CEO & Investor Conference

SAN RAMON, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
January 21, 2016 16:10 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Presents Observational Study Data in Gastric Cancer Patients at the ASCO 2016 Gastrointestinal Cancers Symposium

SAN RAMON, Calif., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
January 13, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Provides 2016 Outlook

SAN RAMON, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
January 11, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at NobleCon12 - Noble Financial Capital Markets’ Twelfth Annual Investor Conference

SAN RAMON, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
January 07, 2016 09:25 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants

SAN RAMON, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
January 06, 2016 16:25 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants

SAN RAMON, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
December 24, 2015 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces a Change to Its Board of Directors

SAN RAMON, Calif., Dec. 24, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right